Navigation Links
BioMarin to Present at the Barclays Capital Global Healthcare Conference
Date:3/4/2009

NOVATO, Calif., March 4 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Stephen Aselage, Senior Vice President of Global Commercial Development of BioMarin, will present a company update at the Barclays Capital Global Healthcare Conference in Miami on Wednesday, March 11th, 2009 at 2:30 p.m. ET.

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.BMRN.com. A replay of the call will be archived on the site for one week following the call.

About BioMarin

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. Other product candidates include 6R-BH4 for cardiovascular indications, which is currently in Phase 2 clinical development for the treatment of sickle cell disease, and PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in Phase 1 clinical development for the treatment of PKU. For additional information, please visit www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press relea
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. BioMarin Appoints Dr. Henry J. Fuchs as Senior Vice President and Chief Medical Officer
2. BioMarin Supports Observance of Rare Disease Day February 28
3. BioMarin to Present at the 27th Annual J.P. Morgan Healthcare Conference
4. BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent
5. BioMarin Announces Initiation of Clinical Assessment Program for Morquio A Syndrome
6. BioMarin to Present at the Lehman Brothers Global Healthcare Conference
7. BioMarin to Present at the Cowen and Company 28th Annual Healthcare Conference
8. BioMarin to Host Fourth Quarter and Full Year 2007 Financial Results Conference Call and Webcast on Tuesday, February 26 at 5:00 p.m. ET (23:00 CET)
9. Fairview Specialty Pharmacy Signs Contract With BioMarin for Distribution of Kuvan(TM)
10. BioMarin Re-Acquires Rights to Kuvan in Canada From Merck Serono
11. BioMarin Provides Grant to NORD to Expand PKU Patient Support Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... (PRWEB) December 17, 2014 HeartMath® ... authorities on stress, heart rate variability (HRV), heart ... licensing its extensive HRV databases and algorithms to ... opportunities will enable HeartMath’s partners to offer its ... extensive research, as well as its normative HRV ...
(Date:12/17/2014)... NY (PRWEB) December 17, 2014 Project ... who recently brought videos of MIT economist and Obamacare ... best-selling author James O’Keefe conducted the interview, which is ... stated that there was intentional mislabeling in the Affordable ... in the bill: A two-hundred-and-fifty billion dollar per year ...
(Date:12/17/2014)... News) -- Greater participation in music classes may benefit ... followed kids in the nonprofit Harmony Project, which provides ... Angeles. Over two years, children who actively participated ... brain processes speech and reading, compared to those with ... active participation in music classes occurred in the same ...
(Date:12/15/2014)... 2014 Cancer researchers have just published ... causes of deadly malignant pleural mesothelioma. Surviving Mesothelioma has ... website. Click here to read it now. ... Cancer Center, and New York’s Langone Medical Center performed ... patients in an effort to pinpoint the genes ...
(Date:12/15/2014)... MD (PRWEB) December 15, 2014 ... services today released “ Social Media Cheat Sheets ,” ... a community that drives results on the top ten ... marketing program. It helps drive awareness, engagement, and customer ... For marketers to make an impact on new networks ...
Breaking Medicine News(10 mins):Health News:HeartMath® Inc.’s HRV Platform Solutions Available for Licensing 2Health News:HeartMath® Inc.’s HRV Platform Solutions Available for Licensing 3Health News:Project Veritas: James O’Keefe Interviews the Man Who Discovered Jonathan Gruber Videos 2Health News:Music Classes Boost Language Skills, Study Says 2Health News:New Study Reveals Genetic Mutations That May Trigger Mesothelioma, According to Surviving Mesothelioma 2Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 2Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 3
... through in the medical field was seen when Pharma major ... who were the instigators for the vaccine//, marketed the latest ... in India and various measures are to be taken to ... a virus which has an incubation period of almost a ...
... quarrels and arguments can delay wound healing according to a ... edition of New Scientist//. ,.,Researchers at Ohio State University ... arguments for about half hour daily can have delayed wound ... problems can also cause reduced body immunity. ,42 married ...
... which intends to stabilize the rates of HIV by the ... US dollars to HIV infected individuals on a monthly basis//. ... HIV infection to below 0.3 percent by 2010. The current ... ,Under a recent government decision, poor HIV carriers living ...
... patient with Her-2/neu positive was helped by her Wangaratta ... drug which costs her more than $70,000.// The fund ... community which could help her to buy Herceptin drug ... more resistant to chemotherapy and anti-estrogen therapy such as ...
... a novel finding that love and addiction may go ... the physiological effects manifested as a result of dopamine ... more than a simulation of the effects observed following ... love and drug abuse leaves the user with an ...
... program with safe and tolerable exercise can be given ... them to have a better heart function//. The study ... of Cardiologist, Jonathan Rhodes. ,The study was ... 8 to 17 with severe congenital heart disease and ...
Cached Medicine News:Health News:‘Marriage Squabbles’ bad for both Emotional and Physical Wound 2Health News:Love And Drug Addiction Share The Same Chemistry 2
(Date:12/17/2014)... 17, 2014  Northstar Global Business Services, Inc. ... (DTC) has made their final decision and has ... Company,s stock effective December 15, 2014, and has ... depository and book entry transfer services. All deposit restrictions ... once again fully "DTC Eligible", and has resumed ...
(Date:12/17/2014)... SCOTTSDALE, Ariz. , Dec. 17, 2014 /PRNewswire/ ... of state-of-the-art interactive music products, today announced that ... Ltd, a leading manufacturer and supplier of innovative ... As part of the agreement, RSL ... Facility bundled solution specifically configured for use within ...
(Date:12/17/2014)... LOS ANGELES , Dec. 17, 2014 /PRNewswire/ ... that the US Patent and Trademark Office (USPTO) ... candidate ICT-107, a dendritic cell-based immunotherapeutic vaccine targeting ... glioblastoma. The claims of US Patent No. 8,871,211, ... treating neural cancer by administering a dendritic cell ...
Breaking Medicine Technology:Northstar announces that the DTC chill on MDIN has been officially lifted 2Northstar announces that the DTC chill on MDIN has been officially lifted 3Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2
...
...
Ascent Primary Knee System with cruciate retaining, posterior stabilized and constrained components...
Ascent Primary Knee System with cruciate retaining, posterior stabilized and constrained components...
Medicine Products: